Hi Logicalthought, I think the 2 doctors are speaking their personal thoughts rather than from published work. Currently,
Delcath is running a Phase II trial that includes a primary liver cancer (hepatocellular carcinoma) arm. Since up to 80% of primary liver cancer patients suffer from cirrhosis of the liver, I find it hard to believe that the Phase II trial would not contain any patients who...